#Open journalism No news is bad news

Your contributions will help us continue to deliver the stories that are important to you

Support The Journal
Dublin: 18°C Monday 21 June 2021
Advertisement

US expands use of Pfizer’s Covid-19 vaccine to include adolescents

Doses could be administered to 12- to 15-year-olds as soon as Thursday.

US REGULATORS HAVE expanded the use of Pfizer’s Covid-19 vaccine to younger teenagers.

Doses could be administered as soon as Thursday after a federal vaccine advisory committee issues recommendations for using the two-dose vaccine in 12- to 15-year-olds, with an announcement expected tomorrow.

Most Covid-19 vaccines worldwide have been authorised for adults.

Pfizer’s vaccine is being used in multiple countries for teens as young as 16, with Canada recently becoming the first to expand use to 12 and up.

Parents, school administrators and public health officials elsewhere have eagerly awaited approval for the shot to be made available to more kids.

“This is a watershed moment in our ability to fight back the Covid-19 pandemic,” Pfizer senior vice president Dr Bill Gruber, told The Associated Press.

The Food and Drug Administration (FDA) declared that the Pfizer vaccine is safe and offers strong protection for younger teens based on testing of more than 2,000 US volunteers ages 12 to 15.

The agency noted there were no cases of Covid-19 among fully vaccinated adolescents compared with 16 among kids given dummy shots.

More intriguing, researchers found the kids developed higher levels of virus-fighting antibodies than earlier studies measured in young adults.

The younger teens received the same vaccine dosage as adults and had the same side effects, mostly sore arms and flu-like fever, chills or aches that signal a revved-up immune system, especially after the second dose.

#Open journalism No news is bad news Support The Journal

Your contributions will help us continue to deliver the stories that are important to you

Support us now

Pfizer’s testing in adolescents “met our rigorous standards”, FDA vaccine chief doctor Peter Marks said.

“Having a vaccine authorised for a younger population is a critical step in continuing to lessen the immense public health burden caused by the Covid-19 pandemic,” he added.

Pfizer and its German partner BioNTech recently requested similar authorisation in the European Union, with other countries to follow.

The latest news is welcome for US families struggling to decide what activities are safe to resume when the youngest family members remain unvaccinated.

About the author:

Press Association

Read next:

COMMENTS (25)

This is YOUR comments community. Stay civil, stay constructive, stay on topic. Please familiarise yourself with our comments policy here before taking part.
write a comment

    Leave a commentcancel